Interleukin 36α Serum Level in Egyptian Patients with Systemic Lupus Erythematosus and its relation to Disease Activity

Abstract

____________________________________ Background: Systemic lupus erythematosus (SLE) is a systemic illness marked by clinical variability, unpredictable outcome, and recurring flares. Interleukin 36α is crucial for innate immunity. It is strongly hypothesized that IL-36 has an impact on SLE pathogenesis. Aim: Assessing the link between interleukin 36α levels and disease